PEISERT DANIEL A. (SVP and CFO) purchased 32.8% of their position (14K shares) of ASSERTIO THERAPEUTICS, INC on the open market
Open‑market purchase worth $21.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 8/20/2019ACC: 0001005201-19-000107
Officer· SVP and CFO
Since Dec 2018
+14K
Net shares
Net buyer
$21.0K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
14K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+10K
Price / share
$1.52
Trade value
$15.20K
% of position
23.4%
8/20/2019
42.66K→52.66K
Common Stock
Direct
Shares
+4K
Price / share
$1.45
Trade value
$5.80K
% of position
7.6%
8/20/2019
52.66K→56.66K
Total
Net shares
+14K
Net value
$21K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/20/2019 | P · Purchase | +10K | $1.52 | $15.20K | 23.4% | 42.66K | 52.66K |
| Common Stock Direct | 8/20/2019 | P · Purchase | +4K | $1.45 | $5.80K | 7.6% | 52.66K | 56.66K |
| Total | +14K | $21K | ||||||
Derivative Transactions0
No derivative transactions reported